NASDAQ:BPMC
Blueprint Medicines Corporation Stock News
$104.96
-1.68 (-1.58%)
At Close: May 17, 2024
Roche collaborates with Blueprint Medicines to bring a new treatment to people with RET-altered cancers
12:00am, Tuesday, 14'th Jul 2020
Roche will obtain co-development and co-commercialisation rights for pralsetinib, an investigational, precision therapy in late-stage development for...
Blueprint Medicines : Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | MarketScreener
08:02pm, Thursday, 02'nd Jul 2020Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
08:01pm, Thursday, 02'nd Jul 2020
Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that, effective on July 1, 2
Blueprint Medicines Files NDA to FDA for Pralsetinib in MTC
04:25pm, Thursday, 02'nd Jul 2020
Blueprint Medicines (BPMC) files an NDA to the FDA for pralsetinib to treat patients with advanced/metastatic RET mutant medullary thyroid cancer and RET fusion-positive thyroid cancers. Stock up.
Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced the submission of a New Drug
Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that The Lancet Oncology pub
SHANGHAI, China, June 28, 2020 (GLOBE NEWSWIRE) -- On June 29, 2020, Burning Rock Biotech Limited (NASDAQ: BNR) announced a strategic partnership with...
BLU G90 heralds company’s jump into an Android 10 world
10:31am, Thursday, 25'th Jun 2020
It has definitely been a long while since we’ve heard from BLU Products. The Florida-based company best known for its wallet-friendly smartphones practically stepped away from the spotlight a…
Debra Durso-Bumpus Sells 2,500 Shares of Blueprint Medicines Corp (NASDAQ:BPMC) Stock
06:18am, Wednesday, 24'th Jun 2020
Blueprint Medicines Corp (NASDAQ:BPMC) insider Debra Durso-Bumpus sold 2,500 shares of Blueprint Medicines stock in a transaction that occurred on Thursday, June 18th. The shares were sold at an avera
Geode Capital Management LLC Boosts Holdings in Blueprint Medicines Corp (NASDAQ:BPMC)
07:16am, Sunday, 21'st Jun 2020
Geode Capital Management LLC grew its position in shares of Blueprint Medicines Corp (NASDAQ:BPMC) by 14.8% during the first quarter, according to its most recent disclosure with the Securities & Exch
